Docoh
Loading...

37 results

Filter options loading...
Top filers
Top filing types
Recent filing years
424B5
PCSA Processa Pharmaceuticals Inc
20 Aug 21
Prospectus supplement for primary offering
4:46pm
trials; our ability to recruit and enroll suitable patients in our clinical trials; the timing or likelihood of the accomplishment of various scientific … ; our ability to recruit and enroll suitable patients in our clinical trials; the timing or likelihood of the accomplishment of various scientific
S-3
PCSA Processa Pharmaceuticals Inc
30 Jun 21
Shelf registration
4:02pm
to advance product candidates into, and successfully complete, clinical trials; our ability to recruit and enroll suitable patients in our clinical
424B3
PCSA Processa Pharmaceuticals Inc
12 Apr 21
Prospectus supplement
1:44pm
additional qualified professionals; our ability to advance product candidates into, and successfully complete, clinical trials; our ability to recruit
S-3
PCSA Processa Pharmaceuticals Inc
1 Apr 21
Shelf registration
8:00pm
to advance product candidates into, and successfully complete, clinical trials; our ability to recruit and enroll suitable patients in our clinical
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
professionals; our ability to advance product candidates into, and successfully complete, clinical trials; our ability to recruit and enroll suitable … added responsibilities on members of management, including the need to identify, recruit, maintain, motivate and integrate additional employees
10-Q
2020 Q3
PCSA Processa Pharmaceuticals Inc
12 Nov 20
Quarterly report
4:01pm
assure the SARS-CoV-2 virus will not have an adverse impact on our future planned clinical trials. Similarly, our ability to recruit and retain
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
, including the need to identify, recruit, maintain, motivate and integrate additional employees. In addition, our management may have to divert … choose to operate in the future. If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
, recruit, maintain, motivate and integrate additional employees. In addition, our management may have to divert a disproportionate amount of its attention … . If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new or next
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
growth would impose significant added responsibilities on members of management, including the need to identify, recruit, maintain, motivate … , or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new or next generation product candidates
S-1/A
PCSA Processa Pharmaceuticals Inc
17 Jul 20
IPO registration (amended)
5:25pm
on members of management, including the need to identify, recruit, maintain, motivate and integrate additional employees. In addition, our management may … in the future. If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new
10-K
2019 FY
PCSA Processa Pharmaceuticals Inc
5 Mar 20
Annual report
7:00pm
the need to identify, recruit, maintain, motivate and integrate additional employees. In addition, our management may have to divert a disproportionate … management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new or next generation product
S-1
PCSA Processa Pharmaceuticals Inc
13 Dec 19
IPO registration
5:32pm
to identify, recruit, maintain, motivate and integrate additional employees. In addition, our management may have to divert a disproportionate amount … or not these claims are supported by applicable law or covered by insurance. If we lose key management personnel, or if we fail to recruit additional highly
10-K/A
2018 FY
PCSA Processa Pharmaceuticals Inc
5 Apr 19
Annual report (amended)
9:40pm
growth would impose significant added responsibilities on members of management, including the need to identify, recruit, maintain, motivate … by insurance. If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new
10-K
2018 FY
PCSA Processa Pharmaceuticals Inc
28 Mar 19
Annual report
5:25pm
growth would impose significant added responsibilities on members of management, including the need to identify, recruit, maintain, motivate … by insurance. If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new
424B3
PCSA Processa Pharmaceuticals Inc
9 Nov 18
Prospectus supplement
5:04pm
of management, including the need to identify, recruit, maintain, motivate and integrate additional employees. In addition, our management may have to divert … to recruit additional highly skilled personnel, our ability to identify and develop new or next generation product candidates will be impaired, could result
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Oct 18
IPO registration (amended)
4:19pm
added responsibilities on members of management, including the need to identify, recruit, maintain, motivate and integrate additional employees … management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify and develop new or next generation product
S-1/A
PCSA Processa Pharmaceuticals Inc
9 Oct 18
IPO registration (amended)
5:32pm
the need to identify, recruit, maintain, motivate and integrate additional employees. In addition, our management may have to divert a disproportionate … or not these claims are supported by applicable law or covered by insurance. If we lose key management personnel, or if we fail to recruit additional highly
S-1/A
PCSA Processa Pharmaceuticals Inc
13 Sep 18
IPO registration (amended)
8:00pm
base. Future growth would impose significant added responsibilities on members of management, including the need to identify, recruit, maintain, motivate … or covered by insurance. If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify
S-1
PCSA Processa Pharmaceuticals Inc
29 Jul 18
IPO registration
8:00pm
the need to identify, recruit, maintain, motivate and integrate additional employees. In addition, our management may have to divert a disproportionate … or not these claims are supported by applicable law or covered by insurance. If we lose key management personnel, or if we fail to recruit additional
10-K/A
2017 FY
PCSA Processa Pharmaceuticals Inc
16 Apr 18
Annual report (amended)
8:00pm
. Future growth would impose significant added responsibilities on members of management, including the need to identify, recruit, maintain, motivate … or covered by insurance. If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to identify